ESR1 and breast cancer: IVT BRRIAR inhibited cell proliferation in a dose-dependent manner but did not induce cell death in most non-ER + breast cancer cell lines until the concentration reached at least 0.5 nM (Fig. 5b and Supplementary Fig. 7e).